Last year, NBC Sports even went so far as to allow Coca-Cola Co., Delta, Eli Lilly & Co., Toyota ... (each advertiser’s logo appeared in the upper right-hand corner of the screen during the ...

The trial results are among the pharmaceutical industry's most critical and closely watched of the year, as they bring Eli Lilly's drug one step closer to becoming a new, needle-free alternative ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly (NYSE:LLY) we detected 9 trades. If we consider the specifics of ...

Eli Lilly (LLY) has launched its weight-loss and diabetes drug, Mounjaro (tirzepatide), in India, securing a first-mover advantage in a market with a large obese population. This move positions ...

Eli Lilly is set to keep growing its revenue at a strong pace in the next five years. The company is likely to add important medicines to its lineup. Eli Lilly's shares look attractive right now.

As the contentious debate over compounded weight loss drugs continues, Eli Lilly is stepping out with an ad campaign ... “You don’t need a prescription, and those government regulators have no hand in ...

Feb. 26 (UPI) --Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the United States and make the nation the world's leader in ...